This topic did not pass the early rule out stage due to insufficient evidence for actionability. Thus, this topic did not move forward for a full evidence curation and summary report. This topic may be reconsidered if additional evidence becomes available.
Citation successfully copied!
The Actionability Summary Report is not available for this topic because there was insufficient evidence for actionability in the early rule out stage.
Assertions and Scores
Actionability Assertions
| Gene | Condition (MONDO ID) | OMIM ID | Final Assertion |
|---|---|---|---|
| No assertions found. | |||
Early Rule-Out
Early Rule-Out Summary
Findings of Early Rule-Out Assessment
- Is there a qualifying resource, such as a practice guideline or systematic review, for the genetic condition?
- Does the practice guideline or systematic review indicate that the result is actionable in one or more of the following ways?
- Is it actionable in an undiagnosed adult with the condition?
- Is this condition an important health problem?
- Is there at least on known pathogenic variant with at least moderate penetrance (≥40%) or moderate relative risk (≥2) in any population?
a. Patient Management
b. Surveillance or Screening
c. Circumstances to Avoid